logo

For the Inventor, By the Inventor

Hanover, Germany

Reinhard Hempel

This inventor holds 7 USPTO granted patents. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1979-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Hempel. Retrieved from https://idiyas.com/inventor/reinhard-hempel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 146(Granted Patents)


Company Filing History:

goldMedal7 out of 92 
 
Kali-Chemie Pharma Gmbh
 patents

Years Active: 1979-1988

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4722941 - Readily absorbable pharmaceutical compositions of per se poorly (1988-02-02),
2. 4402981 - N.sub.1 -Acyl-N.sub.2 -phenyl-diaminopropanols and pharmaceutical (1983-09-06),
3. 4271193 - N1-Benzoyl-N2-phenyldiaminopropanols and pharmaceutical compositions (1981-06-02),
4. 4263313 - Topical pharmaceutical formulations, carrier compositions therefor, and (1981-04-21),
5. 4202888 - Readily enterally absorbable pharmaceutical compositions of cardiac (1980-05-13),
6. 4191770 - N.sub.1 -acyl-N.sub.2 -phenyldiaminopropanols and pharmaceutical (1980-03-04),
7. 4177287 - Pharmaceutical compositions of N.sub.1 -acyl-N.sub.2 (1979-12-04),

Title: Reinhard Hempel: Innovator in Pharmaceutical Compositions

Introduction

Reinhard Hempel is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of readily absorbable pharmaceutical compositions. With a total of 7 patents to his name, Hempel's work has had a considerable impact on the medical community.

Latest Patents

Hempel's latest patents include innovative formulations that enhance the absorption of pharmacologically active agents that are typically poorly absorbable. One of his key inventions involves a pharmaceutical composition that combines a pharmacologically effective amount of active agents with a vehicle containing an absorption-enhancing amount of medium-chain fatty acids. This preparation is particularly suited for various pharmacological applications, including cardiac glycosides, steroids, antibiotics, and local anesthetics. Additionally, he has developed N.sub.1 -acyl-N.sub.2 -phenyl-diaminopropanols, which exhibit ulcer-inhibiting activities, and pharmaceutical compositions effective in treating and preventing ulcers.

Career Highlights

Reinhard Hempel is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to the creation of effective treatments that address significant medical needs.

Collaborations

Hempel has collaborated with esteemed colleagues such as Hans Liepmann and Rolf Hueschens, contributing to a dynamic research environment that fosters innovation and excellence in pharmaceutical sciences.

Conclusion

Reinhard Hempel's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective medical treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…